Practice Implications
pain
Screening trials continue to be recommended by clinical guidelines and required by regulators. The FDA recently issued a letter to healthcare providers reminding of the importance of conducting a screening trial to confirm satisfactory pain relief before implanting a SCS device.We do not suggest that screening trials should be eradicated, but they should not be made mandatory. An informed decision on whether to perform a screening trial should be based on professional judgment and patient preferences, considering the advantages and disadvantages of screening trials.